Primary Site >> Pancreatic Cancer
Gene >> HSP90AA1
| 1. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2000 Sep;19(3):329-34. | ||||||||||
| Title: | Induction and membrane expression of heat shock proteins in heat-treated HPC-4 cells is correlated with increased resistance to LAK-mediated lysis. | ||||||||||
| Author: | Vendetti, S|Cicconi, R|Piselli, P|Vismara, D|Cassol, M|Delpino, A | ||||||||||
| PMID: | 11144526 | ||||||||||
| 2. | |||||||||||
| Journal: | J Nippon Med Sch. 2000 Jun;67(3):177-85. | ||||||||||
| Title: | Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma. | ||||||||||
| Author: | Ogata, M|Naito, Z|Tanaka, S|Moriyama, Y|Asano, G | ||||||||||
| PMID: | 10851351 | ||||||||||
| 3. | |||||||||||
| Journal: | Clin Cancer Res. 2007 Nov 1;13(21):6459-68. | ||||||||||
| Title: | Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotop | ||||||||||
| Author: | Lang, Sven A|Moser, Christian|Gaumann, Andreas|Klein, Dagmar|Glockzin, Gabriel|Popp, Felix C|Dahlke, Marc H|Piso, Pompiliu|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver | ||||||||||
| PMID: | 17975158 | ||||||||||
| 4. | |||||||||||
| Journal: | Mol Carcinog. 2007 Jun;46(6):466-75. | ||||||||||
| Title: | Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition. | ||||||||||
| Author: | Burkitt, Michael|Magee, Conor|O'Connor, David|Campbell, Fiona|Cornford, Philip|Greenhalf, William | ||||||||||
| PMID: | 17219417 | ||||||||||
| 5. | |||||||||||
| Journal: | Clin Cancer Res. 2008 Mar 15;14(6):1831-9. | ||||||||||
| Title: | Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. | ||||||||||
| Author: | Cao, Xianhua|Bloomston, Mark|Zhang, Tao|Frankel, Wendy L|Jia, Guang|Wang, Bing|Hall, Nathan C|Koch, Regina M|Cheng, Hao|Knopp, Michael V|Sun, Duxin | ||||||||||
| PMID: | 18347186 | ||||||||||
| 6. | |||||||||||
| Journal: | Mol Cancer Ther. 2008 Oct;7(10):3275-84. | ||||||||||
| Title: | Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. | ||||||||||
| Author: | Song, Dongweon|Chaerkady, Raghothama|Tan, Aik Choon|Garcia-Garcia, Elena|Nalli, Anuradha|Suarez-Gauthier, Ana|Lopez-Rios, Fernando|Zhang, Xian Feng|Solomon, Anna|Tong, Jeffrey|Read, Margaret|Fritz, Christian|Jimeno, Antonio|Pandey, Akhilesh|Hidalgo, Manue | ||||||||||
| PMID: | 18852131 | ||||||||||
| 7. | |||||||||||
| Journal: | Clin Cancer Res. 2008 Oct 15;14(20):6663-73. | ||||||||||
| Title: | Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors. | ||||||||||
| Author: | de Bono, Johann S|Kristeleit, Rebecca|Tolcher, Anthony|Fong, Peter|Pacey, Simon|Karavasilis, Vasilios|Mita, Monica|Shaw, Heather|Workman, Paul|Kaye, Stan|Rowinsky, Eric K|Aherne, Wynne|Atadja, Peter|Scott, Jeffrey W|Patnaik, Amita | ||||||||||
| PMID: | 18927309 | ||||||||||
| 8. | |||||||||||
| Journal: | Biochem Pharmacol. 2010 Feb 15;79(4):542-51. | ||||||||||
| Title: | Withaferin A targets heat shock protein 90 in pancreatic cancer cells. | ||||||||||
| Author: | Yu, Yanke|Hamza, Adel|Zhang, Tao|Gu, Mancang|Zou, Peng|Newman, Bryan|Li, Yanyan|Gunatilaka, A A Leslie|Zhan, Chang-Guo|Sun, Duxin | ||||||||||
| PMID: | 19769945 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncol Rep. 2010 Jun;23(6):1709-14. | ||||||||||
| Title: | HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells. | ||||||||||
| Author: | Adachi, Seiji|Yasuda, Ichiro|Nakashima, Masanori|Yamauchi, Takahiro|Yamauchi, Junichi|Natsume, Hideo|Moriwaki, Hisataka|Kozawa, Osamu | ||||||||||
| PMID: | 20428829 | ||||||||||
| 10. | |||||||||||
| Journal: | Mol Pharm. 2010 Oct 4;7(5):1576-84. | ||||||||||
| Title: | MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells. | ||||||||||
| Author: | Zhang, Tao|Li, Yanyan|Zhu, Zhenkun|Gu, Mancang|Newman, Bryan|Sun, Duxin | ||||||||||
| PMID: | 20669973 | ||||||||||
| 11. | |||||||||||
| Journal: | J Mol Med (Berl). 2010 Dec;88(12):1243-53. | ||||||||||
| Title: | Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. | ||||||||||
| Author: | Yadav, Vivek R|Sung, Bokyung|Prasad, Sahdeo|Kannappan, Ramaswamy|Cho, Sung-Gook|Liu, Mingyao|Chaturvedi, Madan M|Aggarwal, Bharat B | ||||||||||
| PMID: | 20798912 | ||||||||||
| 12. | |||||||||||
| Journal: | BMC Cancer. 2010 Dec 3;10:668. | ||||||||||
| Title: | Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. | ||||||||||
| Author: | Hackl, Christina|Lang, Sven A|Moser, Christian|Mori, Akira|Fichtner-Feigl, Stefan|Hellerbrand, Claus|Dietmeier, Wolfgang|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver | ||||||||||
| PMID: | 21129190 | ||||||||||
| 13. | |||||||||||
| Journal: | J Transl Med. 2011 Jan 14;9:8. | ||||||||||
| Title: | Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. | ||||||||||
| Author: | Horibe, Tomohisa|Kohno, Masayuki|Haramoto, Mari|Ohara, Koji|Kawakami, Koji | ||||||||||
| PMID: | 21235734 | ||||||||||
| 14. | |||||||||||
| Journal: | Proteomics. 2011 Dec;11(24):4638-47. | ||||||||||
| Title: | Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells. | ||||||||||
| Author: | Zhang, Lifeng|Pang, Eric|Loo, Rachel R Ogorzalek|Rao, Jianyu|Go, Vay-Liang W|Loo, Joseph A|Lu, Qing-Yi | ||||||||||
| PMID: | 22116673 | ||||||||||
| 15. | |||||||||||
| Journal: | Bioorg Med Chem. 2011 Dec 1;19(23):7151-7. | ||||||||||
| Title: | Targeting pancreatic cancer with a G-quadruplex ligand. | ||||||||||
| Author: | Gunaratnam, Mekala|de la Fuente, Maria|Hampel, Sonja M|Todd, Alan K|Reszka, Anthony P|Schatzlein, Andreas|Neidle, Stephen | ||||||||||
| PMID: | 22041170 | ||||||||||
| 16. | |||||||||||
| Journal: | Nutr Cancer. 2011;63(7):1151-9. | ||||||||||
| Title: | Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function. | ||||||||||
| Author: | Li, Yanyan|Zhang, Tao|Schwartz, Steven J|Sun, Duxin | ||||||||||
| PMID: | 21875325 | ||||||||||
| 17. | |||||||||||
| Journal: | Cancer Lett. 2011 Jul 28;306(2):180-9. | ||||||||||
| Title: | RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. | ||||||||||
| Author: | Walsh, Naomi|Larkin, AnneMarie|Swan, Niall|Conlon, Kevin|Dowling, Paul|McDermott, Ray|Clynes, Martin | ||||||||||
| PMID: | 21470770 | ||||||||||
| 18. | |||||||||||
| Journal: | J Pharmacol Exp Ther. 2011 Mar;336(3):874-80. | ||||||||||
| Title: | Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells. | ||||||||||
| Author: | Siegel, David|Shieh, Biehuoy|Yan, Chao|Kepa, Jadwiga K|Ross, David | ||||||||||
| PMID: | 21156818 | ||||||||||
| 19. | |||||||||||
| Journal: | J Surg Res. 2012 Jul;176(1):147-53. | ||||||||||
| Title: | Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG. | ||||||||||
| Author: | Liu, Heping|Zhang, Ti|Chen, Rong|McConkey, David J|Ward, John F|Curley, Steven A | ||||||||||
| PMID: | 22099584 | ||||||||||
| 20. | |||||||||||
| Journal: | Anticancer Res. 2012 Feb;32(2):427-37. | ||||||||||
| Title: | Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors. | ||||||||||
| Author: | Moser, Christian|Lang, Sven A|Hackl, Christina|Zhang, Hong|Lundgren, Karen|Hong, Victor|McKenzie, Andres|Weber, Bernhard|Park, Jung S|Schlitt, Hans J|Geissler, Edward K|Jung, Young D|Stoeltzing, Oliver | ||||||||||
| PMID: | 22287729 | ||||||||||
| 21. | |||||||||||
| Journal: | Anticancer Res. 2012 Jul;32(7):2551-61. | ||||||||||
| Title: | Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. | ||||||||||
| Author: | Moser, Christian|Lang, Sven A|Hackl, Christina|Wagner, Christine|Scheiffert, Eva|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver | ||||||||||
| PMID: | 22753713 | ||||||||||
| 22. | |||||||||||
| Journal: | Hum Mol Genet. 2012 Nov 1;21(21):4615-27. | ||||||||||
| Title: | Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells. | ||||||||||
| Author: | Giessrigl, Benedikt|Krieger, Sigurd|Rosner, Margit|Huttary, Nicole|Saiko, Philipp|Alami, Mouad|Messaoudi, Samir|Peyrat, Jean-Francois|Maciuk, Alexandre|Gollinger, Michaela|Kopf, Sabine|Kazlauskas, Egidijus|Mazal, Peter|Szekeres, Thomas|Hengstschlager, Mar | ||||||||||
| PMID: | 22843495 | ||||||||||
| 23. | |||||||||||
| Journal: | Cancer Gene Ther. 2013 Dec;20(12):663-70. | ||||||||||
| Title: | Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma. | ||||||||||
| Author: | Zhang, Z|Kawamura, K|Jiang, Y|Shingyoji, M|Ma, G|Li, Q|Hu, J|Qi, Y|Liu, H|Zhang, F|Kang, S|Shan, B|Wang, S|Chada, S|Tagawa, M | ||||||||||
| PMID: | 24263157 | ||||||||||
| 24. | |||||||||||
| Journal: | Radiat Oncol. 2013 Feb 28;8:42. | ||||||||||
| Title: | Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990. | ||||||||||
| Author: | Milanovic, Dusan|Firat, Elke|Grosu, Anca Ligia|Niedermann, Gabriele | ||||||||||
| PMID: | 23448094 | ||||||||||
| 25. | |||||||||||
| Journal: | Pancreas. 2013 Apr;42(3):411-21. | ||||||||||
| Title: | Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors. | ||||||||||
| Author: | Gilbert, Judith A|Adhikari, Laura J|Lloyd, Ricardo V|Halfdanarson, Thorvardur R|Muders, Michael H|Ames, Matthew M | ||||||||||
| PMID: | 23211371 | ||||||||||
| 26. | |||||||||||
| Journal: | PLoS One. 2013;8(2):e57508. | ||||||||||
| Title: | InterAKTions with FKBPs--mutational and pharmacological exploration. | ||||||||||
| Author: | Fabian, Anne-Katrin|Marz, Andreas|Neimanis, Sonja|Biondi, Ricardo M|Kozany, Christian|Hausch, Felix | ||||||||||
| PMID: | 23469007 | ||||||||||
| 27. | |||||||||||
| Journal: | Invest New Drugs. 2014 Feb;32(1):68-74. | ||||||||||
| Title: | Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. | ||||||||||
| Author: | Gu, Mancang|Yu, Yanke|Gunaherath, G M Kamal B|Gunatilaka, A A Leslie|Li, Dapeng|Sun, Duxin | ||||||||||
| PMID: | 23887853 | ||||||||||
| 28. | |||||||||||
| Journal: | Histol Histopathol. 2014 Apr;29(4):423-31. | ||||||||||
| Title: | Melatonin influences pancreatic cancerogenesis. | ||||||||||
| Author: | Jaworek, Jolanta|Leja-Szpak, Anna | ||||||||||
| PMID: | 24258787 | ||||||||||
| 29. | |||||||||||
| Journal: | JOP. 2014 Mar 10;15(2):110-3. | ||||||||||
| Title: | Novel agents for the treatment of pancreatic cancer. | ||||||||||
| Author: | Brennan, Gregory T|Relias, Valerie|Saif, Muhammad Wasif | ||||||||||
| PMID: | 24618430 | ||||||||||
| 30. | |||||||||||
| Journal: | Int J Biochem Cell Biol. 2014 Aug;53:224-36. | ||||||||||
| Title: | Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer. | ||||||||||
| Author: | Li, Lin|Leung, Po Sing | ||||||||||
| PMID: | 24875648 | ||||||||||
| 31. | |||||||||||
| Journal: | Curr Cancer Drug Targets. 2014;14(7):671-83. | ||||||||||
| Title: | Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways. | ||||||||||
| Author: | Xue, Nina|Jin, Jing|Liu, Di|Yan, Rui|Zhang, Sen|Yu, Xiaoming|Chen, Xiaoguang | ||||||||||
| PMID: | 25219422 | ||||||||||
| 32. | |||||||||||
| Journal: | Cancer Lett. 2015 Feb 28;357(2):557-65. | ||||||||||
| Title: | Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer. | ||||||||||
| Author: | Nagaraju, Ganji Purnachandra|Zhu, Shijun|Ko, Jasmine E|Ashritha, Nakkana|Kandimalla, Ramesh|Snyder, James P|Shoji, Mamoru|El-Rayes, Bassel F | ||||||||||
| PMID: | 25497868 | ||||||||||
| 33. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2015 Feb;42(2):154-8. | ||||||||||
| Title: | [Treatment with carbon-ion radiotherapy and its combinations -- basic biological studies and investigations at the National Institute of Radiological Sciences]. | ||||||||||
| Author: | Imai, Takashi | ||||||||||
| PMID: | 25743134 | ||||||||||
| 34. | |||||||||||
| Journal: | Invest New Drugs. 2015 Aug;33(4):963-8. | ||||||||||
| Title: | Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study. | ||||||||||
| Author: | Pedersen, Katrina S|Kim, George P|Foster, Nathan R|Wang-Gillam, Andrea|Erlichman, Charles|McWilliams, Robert R | ||||||||||
| PMID: | 25952464 | ||||||||||
| 35. | |||||||||||
| Journal: | Int J Biol Macromol. 2015 Sep;80:253-9. | ||||||||||
| Title: | Molecular docking study, synthesis and biological evaluation of Mannich bases as Hsp90 inhibitors. | ||||||||||
| Author: | Gupta, Sayan Dutta|Bommaka, Manish Kumar|Mazaira, Gisela I|Galigniana, Mario D|Subrahmanyam, Chavali Venkata Satya|Gowrishankar, Naryanasamy Lachmana|Raghavendra, Nulgumnalli Manjunathaiah | ||||||||||
| PMID: | 26116388 | ||||||||||
| 36. | |||||||||||
| Journal: | Eur J Cancer. 2016 Jan;52:109-19. | ||||||||||
| Title: | Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib. | ||||||||||
| Author: | Nagaraju, Ganji Purnachandra|Mezina, Anya|Shaib, Walid L|Landry, Jerome|El-Rayes, Bassel F | ||||||||||
| PMID: | 26682870 | ||||||||||
| 37. | |||||||||||
| Journal: | Pathologe. 2016 Nov;37(Suppl 2):191-195. | ||||||||||
| Title: | [Pancreatic acinar neoplasms : Comparative molecular characterization]. | ||||||||||
| Author: | Bergmann, F | ||||||||||
| PMID: | 27807633 | ||||||||||
| 38. | |||||||||||
| Journal: | Int J Pharm. 2016 Sep 10;511(1):648-658. | ||||||||||
| Title: | Dual mode of cancer cell destruction for pancreatic cancer therapy using Hsp90 inhibitor loaded polymeric nano magnetic formulation. | ||||||||||
| Author: | Rochani, Ankit K|Balasubramanian, Sivakumar|Ravindran Girija, Aswathy|Raveendran, Sreejith|Borah, Ankita|Nagaoka, Yutaka|Nakajima, Yoshikata|Maekawa, Toru|Kumar, D Sakthi | ||||||||||
| PMID: | 27469073 | ||||||||||
| 39. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2016 Sep;78(3):541-5. | ||||||||||
| Title: | A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer. | ||||||||||
| Author: | Renouf, D J|Hedley, D|Krzyzanowska, M K|Schmuck, M|Wang, L|Moore, M J | ||||||||||
| PMID: | 27422303 | ||||||||||
| 40. | |||||||||||
| Journal: | Oncotarget. 2017 Jan 17;8(3):4399-4409. | ||||||||||
| Title: | Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. | ||||||||||
| Author: | Bobrov, Egor|Skobeleva, Natalia|Restifo, Diana|Beglyarova, Natalya|Cai, Kathy Q|Handorf, Elizabeth|Campbell, Kerry|Proia, David A|Khazak, Vladimir|Golemis, Erica A|Astsaturov, Igor | ||||||||||
| PMID: | 27779106 | ||||||||||
| 41. | |||||||||||
| Journal: | Apoptosis. 2017 Mar;22(3):369-380. | ||||||||||
| Title: | HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. | ||||||||||
| Author: | Ghadban, Tarik|Dibbern, Judith L|Reeh, Matthias|Miro, Jameel T|Tsui, Tung Y|Wellner, Ulrich|Izbicki, Jakob R|Gungor, Cenap|Vashist, Yogesh K | ||||||||||
| PMID: | 27878398 | ||||||||||
| 42. | |||||||||||
| Journal: | Cancer Lett. 2017 Aug 28;402:110-116. | ||||||||||
| Title: | Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer. | ||||||||||
| Author: | Nagaraju, Ganji Purnachandra|Wu, Christina|Merchant, Neha|Chen, Zhengjia|Lesinski, Gregory B|El-Rayes, Bassel F | ||||||||||
| PMID: | 28583846 | ||||||||||
| 43. | |||||||||||
| Journal: | Cancer. 2017 Dec 15;123(24):4924-4933. | ||||||||||
| Title: | Inhibiting heat shock protein 90 and the ubiquitin-proteasome pathway impairs metabolic homeostasis and leads to cell death in human pancreatic cancer cells. | ||||||||||
| Author: | Belalcazar, Astrid|Shaib, Walid L|Farren, Matthew R|Zhang, Chao|Chen, Zhengjia|Yang, Lily|Lesinski, Gregory B|El-Rayes, Bassel F|Nagaraju, Ganji Purnachandra | ||||||||||
| PMID: | 28841232 | ||||||||||
| 44. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Aug 10;10:3991-4005. | ||||||||||
| Title: | Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases. | ||||||||||
| Author: | Xie, Zu-Cheng|Dang, Yi-Wu|Wei, Dan-Ming|Chen, Peng|Tang, Rui-Xue|Huang, Qian|Liu, Jiang-Hua|Luo, Dian-Zhong | ||||||||||
| PMID: | 28860807 | ||||||||||
| 45. | |||||||||||
| Journal: | Cancer Sci. 2018 Feb;109(2):373-383. | ||||||||||
| Title: | PRDM14 directly interacts with heat shock proteins HSP90alpha and glucose-regulated protein 78. | ||||||||||
| Author: | Moriya, Chiharu|Taniguchi, Hiroaki|Nagatoishi, Satoru|Igarashi, Hisayoshi|Tsumoto, Kouhei|Imai, Kohzoh | ||||||||||
| PMID: | 29178343 | ||||||||||
| 46. | |||||||||||
| Journal: | Amino Acids. 2018 Jul;50(7):897-907. | ||||||||||
| Title: | PET imaging of Hsp90 expression in pancreatic cancer using a new (64)Cu-labeled dimeric Sansalvamide A decapeptide. | ||||||||||
| Author: | Wang, Xiaohui|Zhang, Jun|Wu, Hubing|Li, Yumin|Conti, Peter S|Chen, Kai | ||||||||||
| PMID: | 29691700 | ||||||||||
| 47. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2018 Jun 27;501(3):751-757. | ||||||||||
| Title: | Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK. | ||||||||||
| Author: | Jin, Un-Ho|Karki, Keshav|Kim, Sang-Bae|Safe, Stephen | ||||||||||
| PMID: | 29758193 | ||||||||||